FolioLanternBeta
VCYTVeracyte, Inc.

Karin Eastham

Director at Veracyte, Inc., as of Jun 22, 2026Sold $1.5M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
33K
shares sold, past 12 months
3
days with sales
$909K
largest single day, Dec 5, 2025
2
companies filed for

Share of stake sold and shares held at Veracyte, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $387K under a disclosed planNovDec 2025: $909K under a disclosed plan$909KDecJanFebMarAprMayJun 2026: $197K under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Veracyte, Inc. (VCYT)DirectorOct 29, 2013Jun 22, 2026
Illumina, Inc. (ILMN)Former DirectorAug 3, 2004May 28, 2019

Also a director at

Illumina, Inc. (ILMN) (no filing in the last 18 months)

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.